HIV trial
Immune response may be harnessed to control HIV, RIO study shows
New antibody therapies could offer alternative to current treatments.
Stories tagged with 'HIV/AIDS'
Birthday Honours
King’s Birthday Honours for Imperial academics
Leading Imperial researchers from across the university have been recognised in the latest King’s Birthday Honours List.
HORIZON EUROPE
Imperial celebrates association to Horizon Europe
Imperial brought together our European and global science communities earlier this week to mark the start of the UK's association to Horizon Europe.
HIV help
Engaging heterosexual men more effectively could slash HIV infections in Uganda
A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.
1
HIV breakthrough
Genetic variant linked to lower levels of HIV virus in people of African descent
Genetic study identifies Africa-specific variant near CHD1L gene associated with lower HIV-1 viral load in populations of African descent.
Feature
HIV & HTLV-1 Research
Retrovirology Symposium: A celebration of 60 years of friendship & collaboration
The day celebrated the semi-retirement of Professor Jonathan Weber and Professor Charles Bangham, who first met at junior school 60 years ago.
Audio
Planet pod
Podcast: Data poisoning, living with HIV, and climate art
In this edition: How hackers can ‘poison’ AI training data, the modern experience of living with HIV, and a climate change art prize.
Feature
Pride HIV Awareness
In conversation: Mental Health and Stigma with HIV, where are we 40 years on?
In this podcast series, we explore the experience of living with HIV and current research at Imperial on mental health and future treatment options.
Patent passport
WE Invent means patent costs are no barrier for Imperial’s women entrepreneurs
Female innovators at Imperial can benefit from a dedicated fund that covers the costs of patenting an invention.
Preventing HIV
Long-acting PrEP injections could help reduce new cases of HIV in United States
Providing more high-risk men with access to a long-acting form of PrEP could help to reduce new cases of HIV in the United States.
